| dbo:abstract |
أب في (بالإنجليزية: AbbVie) شركة صناعات دوائية تعنى باكتشاف وتطوير وتسويق كل من المستحضرات الصيدلانية الحيوية وعقاقير المركبات العضوية الصغيرة. نشأت في عام 2013 بانفصالها عن مختبرات أبوت. (ar) AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. (en) Abbvie (eigene Schreibweise: AbbVie) ist ein Biotechnologie- und Pharmaunternehmen, das 2013 als Abspaltung von Abbott Laboratories gegründet wurde und an der New Yorker Börse NYSE im S&P-100-Index unter dem Symbol „ABBV“ gehandelt wird. Tätig ist das in North Chicago im US-Bundesstaat Illinois ansässige Unternehmen unter anderem in den Bereichen Immunologie, Onkologie und Virologie. Der weltweite Umsatz betrug 2021 56,2 Milliarden US-Dollar. (de) AbbVie es una empresa biotecnológica y farmacéutica estadounidense. Fue fundada en 2013 como una escisión de Abbott Laboratories y cotiza en la Bolsa de Nueva York en el índice S&P 100. Con sede en Lake Bluff (Illinois), la empresa opera en los ámbitos de inmunología, oncología, neurociencia y virología, entre otros. Sus ventas mundiales en 2020 fueron de 45800 millones de dólares. (es) AbbVie est une entreprise américaine spécialisée dans la recherche pharmaceutique. AbbVie recherche et développe des médicaments thérapeutiques pour le traitement de l'arthrite rhumatoïde, du psoriasis, de la maladie de Crohn, de la thyroïde, de la maladie de Parkinson, du VIH, des complications de la mucoviscidose, du faible taux de testostérone, et des complications associées à la maladie rénale chronique. (fr) AbbVie adalah sebuah perusahaan biofarmasi publik asal Amerika yang didirikan pada tahun 2013. Perusahaan ini berasal dari Abbott Laboratories. (in) AbbVie è una multinazionale americana nata nel 2013 dallo spin-off di Abbott Laboratories. Opera nel settore biofarmaceutico con prodotti, sia biologici sia di sintesi chimica, focalizzati su un nucleo di aree terapeutiche specifiche quali l'epatite C (HCV), la neuroscienza, l'immunologia, l'oncologia, le malattie renali e la salute della donna. È quotata dal gennaio 2013 alla Borsa di New York. (it) 애브비(AbbVie)는 2013년 설립된 미국의 공개 거래 생체의약품 기업이다. 애벗 래버러토리스의 기업 분사를 통해 설립되었다. (ko) アッヴィ（英: AbbVie Inc.）は、アメリカ合衆国・イリノイ州・シカゴ北郊のに本社を置き、新薬の研究・開発・販売を行うバイオ医薬品企業。日本法人はアッヴィ合同会社（AbbVie GK）。ニューヨーク証券取引所上場企業（NYSE: ABBV）。 (ja) AbbVie — американская биофармакологическая компания, основанная в 2013 году выделением из Abbott Laboratories. Одна из крупнейших фармацевтических компаний мира. (ru) Abbvie Inc. är ett amerikanskt multinationellt läkemedelsbolag som sysslar huvudsak med forskning inom biomedicin och där de är ledande på både immunologi och virologi. Bolaget bildades 1 januari 2013 när Abbott Laboratories valde att avknoppa sin forskningsenhet till att bli ett självständigt bolag i syfte att maximera värdet på aktieägarnas aktieinnehav samt att man tyckte att sina divisioner stod för långt ifrån varandra för att det skulle vara acceptabelt att vara i samma företagssfär. (sv) 艾伯维（英語：AbbVie）是一家美国生物技术公司，专注于免疫学，病毒学等领域。 (zh) |
| dbo:assets |
1.4653E11 |
| dbo:equity |
1.544E10 |
| dbo:foundingYear |
2013-01-01 (xsd:gYear) |
| dbo:industry |
dbr:Biopharmaceutical |
| dbo:location |
dbr:North_Chicago,_Illinois |
| dbo:netIncome |
1.154E10 |
| dbo:numberOfEmployees |
50000 (xsd:nonNegativeInteger) |
| dbo:operatingIncome |
1.792E10 |
| dbo:product |
dbr:Risankizumab dbr:Ritonavir dbr:Upadacitinib dbr:Venetoclax dbr:Glecaprevir/pibrentasvir dbr:Lopinavir dbr:Adalimumab dbr:Daclizumab dbr:Ibrutinib dbr:Medication |
| dbo:revenue |
5.62E10 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/AbbVie_logo.svg?width=300 |
| dbo:type |
dbr:Public_company |
| dbo:wikiPageExternalLink |
https://www.abbvie.com |
| dbo:wikiPageID |
37665564 (xsd:integer) |
| dbo:wikiPageLength |
35727 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1117536168 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Calico_(company) dbr:Cambridge,_Massachusetts dbr:Ron_Wyden dbr:Pharmacyclics dbr:Research_and_development dbr:Rheumatoid_arthritis dbr:Risankizumab dbr:Ritonavir dbr:Cystic_fibrosis dbr:Ulcerative_colitis dbr:University_of_Chicago dbr:Upadacitinib dbr:Venetoclax dbr:Vertex_Pharmaceuticals dbr:Tax_inversion dbr:Kaletra dbr:Public_company dbr:Neurodegeneration dbc:Biotechnology_companies_of_the_United_States dbr:Corporate_spin-off dbr:Crohn's_disease dbr:Memantine dbr:S&P_100 dbr:S&P_500 dbr:Chief_medical_officer dbr:Galapagos_NV dbr:Genentech dbr:Glecaprevir/pibrentasvir dbr:Multiple_myeloma dbr:NHS_England dbr:Lopinavir dbr:Lopinavir/ritonavir dbr:MIT dbr:Shire_(pharmaceutical_company) dbr:Hal_V._Barron dbr:Synthetic_biology dbr:Technology_and_Construction_Court dbr:CD71 dbr:COVID-19 dbr:COVID-19_pandemic dbr:Abbott_Laboratories dbr:Adalimumab dbr:Allergan dbr:Allergan,_inc dbr:Alphabet_Inc. dbr:Analgesic dbc:American_companies_established_in_2013 dbc:Companies_listed_on_the_New_York_Stock_Exchange dbc:Corporate_spin-offs dbr:Daclizumab dbr:Duvelisib dbr:Alzheimer's_disease dbr:Executive_Vice_President dbr:Federal_Trade_Commission dbr:Fenofibrate dbr:Forest_Laboratories dbr:North_Chicago,_Illinois dbr:Carbon_footprint dbr:Kickback_(bribery) dbr:Hepatitis_C dbr:James_Collins_(bioengineer) dbr:Tax_Cuts_and_Jobs_Act_of_2017 dbr:Arthur_D._Levinson dbr:AstraZeneca dbc:2013_initial_public_offerings dbc:Biopharmaceutical_companies dbc:Companies_based_in_Lake_County,_Illinois dbc:Pharmaceutical_companies_of_the_United_States dbc:2013_establishments_in_Illinois dbc:AbbVie dbc:Abbott_Laboratories dbc:Biotechnology_companies_established_in_2013 dbc:Health_care_companies_based_in_Illinois dbc:Orphan_drug_companies dbc:Pharmaceutical_companies_established_in_2013 dbr:Biopharmaceutical dbr:Biosimilar dbr:Sunnyvale,_California dbr:T_cells dbr:Autoimmune_disease dbr:B-cell_maturation_antigen dbr:Mantle_cell_lymphoma dbr:Ibrutinib dbr:Inflammatory_bowel_disease dbr:New_York_Stock_Exchange dbr:Oncology dbr:Opioid dbr:Cancer_immunotherapy dbr:Probiotic dbr:Medication dbr:Specialty_drug dbr:Humira dbr:Repros_Therapeutics dbr:Age-related_disease dbr:Allergan_plc dbr:PI3K_inhibitor dbr:Synaptic_vesicle_protein_2A dbr:Actavis_plc dbr:Allergan,_plc dbr:United_States_Senate_Finance_Committee dbr:DJS_Antibodies dbr:SDI-118 dbr:TNB-383B |
| dbp:areaServed |
(en) Worldwide (en) |
| dbp:assets |
(en) 1.4653E11 |
| dbp:equity |
1.544E10 |
| dbp:google |
ABBV (en) |
| dbp:industry |
dbr:Biopharmaceutical |
| dbp:keyPeople |
(en) Michael Severino (en) Richard A. Gonzalez (en) |
| dbp:location |
North Chicago, Illinois, U.S. (en) |
| dbp:logo |
AbbVie logo.svg (en) |
| dbp:name |
AbbVie (en) AbbVie Inc. (en) |
| dbp:netIncome |
1.154E10 |
| dbp:numEmployees |
50000 (xsd:integer) |
| dbp:operatingIncome |
1.792E10 |
| dbp:products |
dbr:Medication * Humira (adalimumab) * Imbruvica (ibrutinib) * Venclexta (venetoclax) * Zinbryta (daclizumab) * Kaletra (lopinavir) * Norvir (ritonavir) * Mavyret/Maviret (glecaprevir/pibrentasvir) * Skyrizi (risankizumab) * Rinvoq (upadacitinib) (en) |
| dbp:revenue |
(en) 5.62E10 |
| dbp:secCik |
1551152 (xsd:integer) |
| dbp:symbol |
ABBV (en) |
| dbp:title |
The following is an illustration of the company's major mergers and acquisitions and historical predecessors : (en) |
| dbp:titlestyle |
background:white; (en) |
| dbp:toggle |
left (en) |
| dbp:type |
dbr:Public_company |
| dbp:wikiPageUsesTemplate |
dbt:Authority_control dbt:Citation_needed dbt:Commons_category-inline dbt:Decrease dbt:Hidden_end dbt:Increase dbt:Infobox_company dbt:Official dbt:Reflist dbt:Short_description dbt:Start_date_and_age dbt:URL dbt:Ubl dbt:Tree_list dbt:Tree_list/end dbt:Finance_links dbt:Hidden_start dbt:Pharmaceutical_companies_of_the_United_States |
| dbp:yahoo |
ABBV (en) |
| dcterms:subject |
dbc:Biotechnology_companies_of_the_United_States dbc:American_companies_established_in_2013 dbc:Companies_listed_on_the_New_York_Stock_Exchange dbc:Corporate_spin-offs dbc:2013_initial_public_offerings dbc:Biopharmaceutical_companies dbc:Companies_based_in_Lake_County,_Illinois dbc:Pharmaceutical_companies_of_the_United_States dbc:2013_establishments_in_Illinois dbc:AbbVie dbc:Abbott_Laboratories dbc:Biotechnology_companies_established_in_2013 dbc:Health_care_companies_based_in_Illinois dbc:Orphan_drug_companies dbc:Pharmaceutical_companies_established_in_2013 |
| rdf:type |
owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 dbo:Organisation |
| rdfs:comment |
أب في (بالإنجليزية: AbbVie) شركة صناعات دوائية تعنى باكتشاف وتطوير وتسويق كل من المستحضرات الصيدلانية الحيوية وعقاقير المركبات العضوية الصغيرة. نشأت في عام 2013 بانفصالها عن مختبرات أبوت. (ar) AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. (en) Abbvie (eigene Schreibweise: AbbVie) ist ein Biotechnologie- und Pharmaunternehmen, das 2013 als Abspaltung von Abbott Laboratories gegründet wurde und an der New Yorker Börse NYSE im S&P-100-Index unter dem Symbol „ABBV“ gehandelt wird. Tätig ist das in North Chicago im US-Bundesstaat Illinois ansässige Unternehmen unter anderem in den Bereichen Immunologie, Onkologie und Virologie. Der weltweite Umsatz betrug 2021 56,2 Milliarden US-Dollar. (de) AbbVie es una empresa biotecnológica y farmacéutica estadounidense. Fue fundada en 2013 como una escisión de Abbott Laboratories y cotiza en la Bolsa de Nueva York en el índice S&P 100. Con sede en Lake Bluff (Illinois), la empresa opera en los ámbitos de inmunología, oncología, neurociencia y virología, entre otros. Sus ventas mundiales en 2020 fueron de 45800 millones de dólares. (es) AbbVie est une entreprise américaine spécialisée dans la recherche pharmaceutique. AbbVie recherche et développe des médicaments thérapeutiques pour le traitement de l'arthrite rhumatoïde, du psoriasis, de la maladie de Crohn, de la thyroïde, de la maladie de Parkinson, du VIH, des complications de la mucoviscidose, du faible taux de testostérone, et des complications associées à la maladie rénale chronique. (fr) AbbVie adalah sebuah perusahaan biofarmasi publik asal Amerika yang didirikan pada tahun 2013. Perusahaan ini berasal dari Abbott Laboratories. (in) AbbVie è una multinazionale americana nata nel 2013 dallo spin-off di Abbott Laboratories. Opera nel settore biofarmaceutico con prodotti, sia biologici sia di sintesi chimica, focalizzati su un nucleo di aree terapeutiche specifiche quali l'epatite C (HCV), la neuroscienza, l'immunologia, l'oncologia, le malattie renali e la salute della donna. È quotata dal gennaio 2013 alla Borsa di New York. (it) アッヴィ（英: AbbVie Inc.）は、アメリカ合衆国・イリノイ州・シカゴ北郊のに本社を置き、新薬の研究・開発・販売を行うバイオ医薬品企業。日本法人はアッヴィ合同会社（AbbVie GK）。ニューヨーク証券取引所上場企業（NYSE: ABBV）。 (ja) AbbVie — американская биофармакологическая компания, основанная в 2013 году выделением из Abbott Laboratories. Одна из крупнейших фармацевтических компаний мира. (ru) Abbvie Inc. är ett amerikanskt multinationellt läkemedelsbolag som sysslar huvudsak med forskning inom biomedicin och där de är ledande på både immunologi och virologi. Bolaget bildades 1 januari 2013 när Abbott Laboratories valde att avknoppa sin forskningsenhet till att bli ett självständigt bolag i syfte att maximera värdet på aktieägarnas aktieinnehav samt att man tyckte att sina divisioner stod för långt ifrån varandra för att det skulle vara acceptabelt att vara i samma företagssfär. (sv) 艾伯维（英語：AbbVie）是一家美国生物技术公司，专注于免疫学，病毒学等领域。 (zh) |
| rdfs:label |
AbbVie (en) شركة أب في (ar) Abbvie (de) AbbVie (es) AbbVie (in) AbbVie (fr) AbbVie (it) 애브비 (ko) アッヴィ (ja) AbbVie (ru) Abbvie (sv) 艾伯维 (zh) |
| owl:sameAs |
http://d-nb.info/gnd/1179216946 http://viaf.org/viaf/1457155191921682440005 wikidata:AbbVie dbpedia-ar:AbbVie http://arz.dbpedia.org/resource/شركة_اب_فى dbpedia-da:AbbVie dbpedia-de:AbbVie dbpedia-es:AbbVie dbpedia-fa:AbbVie dbpedia-fi:AbbVie dbpedia-fr:AbbVie dbpedia-he:AbbVie dbpedia-id:AbbVie dbpedia-it:AbbVie dbpedia-ja:AbbVie dbpedia-ko:AbbVie dbpedia-ms:AbbVie dbpedia-ru:AbbVie http://sah.dbpedia.org/resource/Abbvie dbpedia-sv:AbbVie http://uz.dbpedia.org/resource/AbbVie dbpedia-zh:AbbVie https://global.dbpedia.org/id/UFYK |
| prov:wasDerivedFrom |
wikipedia-en:AbbVie?oldid=1117536168&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/AbbVie_logo.svg |
| foaf:homepage |
https://www.abbvie.com |
| foaf:isPrimaryTopicOf |
wikipedia-en:AbbVie |
| foaf:name |
AbbVie Inc. (en) |
| is dbo:parentCompany of |
dbr:Pharmacyclics dbr:Allergan |
| is dbo:wikiPageRedirects of |
dbr:Synlogic dbr:AbbVie_Inc. dbr:ABBV dbr:Abbvie dbr:Abbvie_Inc |
| is dbo:wikiPageWikiLink of |
dbr:Calico_(company) dbr:Cambridge_Antibody_Technology dbr:Cancer_Breakthroughs_2020 dbr:Cariprazine dbr:Prain_Global dbr:List_of_drugs_granted_breakthrough_therapy_designation dbr:National_Health_Council dbr:2021_Connacht_Senior_Football_Championship dbr:Bayh–Dole_Act dbr:Biogen dbr:Depatuxizumab_mafodotin dbr:Annette_Byrne dbr:List_of_Internet_top-level_domains dbr:List_of_largest_mergers_and_acquisitions dbr:List_of_largest_pharmaceutical_mergers_and_acquisitions dbr:Pharmacyclics dbr:Rheaply dbr:Risankizumab dbr:Ritonavir dbr:Robert_Duggan_(venture_capitalist) dbr:Upadacitinib dbr:Veliparib dbr:David_M._Holtzman dbr:Defense_industrial_base dbr:Innovative_Medicines_Canada dbr:List_of_largest_biomedical_companies_by_market_capitalization dbr:List_of_largest_biomedical_companies_by_revenue dbr:List_of_largest_companies_in_the_United_States_by_revenue dbr:List_of_largest_corporate_spin-offs dbr:List_of_largest_selling_pharmaceutical_products dbr:List_of_multinational_corporations dbr:List_of_pharmaceutical_companies dbr:List_of_pharmaceutical_compound_number_prefixes dbr:Tax_inversion dbr:Proprietary_drug dbr:Connacht_Senior_Football_Championship dbr:Corporate_responses_to_the_2022_Russian_invasion_of_Ukraine dbr:Crohn's_&_Colitis_Foundation dbr:S&P_100 dbr:Genta_(company) dbr:National_Organization_for_Rare_Disorders dbr:Seble_Wagaw dbr:Elagolix dbr:Elotuzumab dbr:GSK_plc dbr:Genmab dbr:Glecaprevir dbr:Modimelanotide dbr:Miles_D._White dbr:Synlogic dbr:2020_Connacht_Senior_Football_Championship dbr:Levobupivacaine dbr:Lurie_Children's_Hospital dbr:Shire_(pharmaceutical_company) dbr:Silodosin dbr:Companies_listed_on_the_New_York_Stock_Exchange_(A) dbr:Yvonne_Connolly_Martin dbr:Pharma_Documentation_Ring dbr:Pharmaceutical_Research_and_Manufacturers_of_America dbr:Pharmacy_benefit_management dbr:Puberty_blocker dbr:BIOTECanada dbr:2022_Connacht_Senior_Football_Championship dbr:A-971432 dbr:ABT-436 dbr:AbbVie_Inc. dbr:Abbott_Laboratories dbr:Adalimumab dbr:Advertising_Standards_Canada dbr:Allergan dbr:American_Psychiatric_Association dbr:Editas_Medicine dbr:Paramethadione dbr:List_of_S&P_500_companies dbr:Habitat_for_Humanity dbr:Society_for_Immunotherapy_of_Cancer dbr:Arthritis_Foundation dbr:Access_to_Medicine_Index dbr:Patent_thicket dbr:Reagan-Udall_Foundation dbr:Rely_on_Your_Beliefs_Fund dbr:Asset-Centricity dbr:Association_of_Medical_Microbiology_and_Infectious_Disease_Canada dbr:Philidor_Rx_Services dbr:South_San_Francisco,_California dbr:Ibrutinib dbr:Illinois's_10th_congressional_district dbr:Institute_for_Public_Policy_Research dbr:Intellia_Therapeutics dbr:Kirkland_&_Ellis dbr:Ombitasvir dbr:Canadian_Association_of_Emergency_Physicians dbr:Seagen dbr:Sevoflurane dbr:Sheridan_Road dbr:Medicines_Patent_Pool dbr:Rovalpituzumab_tesirine dbr:Russell_1000_Index dbr:Pharmaceutical_Advertising_Advisory_Board dbr:Research_Park_at_the_University_of_Illinois_Urbana-Champaign dbr:S&P_500_Dividend_Aristocrats dbr:William_Osler_Health_System dbr:ABBV dbr:Abbvie dbr:Abbvie_Inc |
| is dbp:parent of |
dbr:Pharmacyclics dbr:Allergan |
| is foaf:primaryTopic of |
wikipedia-en:AbbVie |
